Early bird registration is open and closes May 2025. Register now

  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Yukiko Kimura

Affiliation/region: Joseph M. Sanzari Childrens Hospital, Hackensack Meridian School Of Medicine, America
Yukiko Kimura - Joseph M. Sanzari Childrens Hospital

Dr Yukiko Kimura is the Chief of Pediatric Rheumatology at the Joseph M Sanzari Children’s Hospital at Hackensack University Medical Center and Professor of Pediatrics at the Hackensack Meridian School of Medicine. Dr Kimura is a clinical researcher and is a founding member and leader of the Childhood Arthritis and Rheumatology Research Alliance CARRA, which is a North America wide pediatric rheumatology research network with over 100 sites and over 500 members. She has held a number of CARRA leadership positions including President, Executive Committee member, JIA Research Committee Chair, and Co Chair of the CARRA Registry and Research Oversight Committee. Dr Kimura was responsible for coleading the establishment of the CARRA Registry for pediatric rheumatic diseases which has enrolled almost 15,000 patients to date which has led to multiple research studies and publications. Dr Kimura also led the development of the consensus treatment plans (CTPs) for systemic JIA and polyarticular JIA, and is the principal investigator for two CARRA multicenter studies of CARRA CTPs for children and adolescents with new onset polyarticular JIA (STOPJIA) and systemic JIA (FROST) which are continuing to provide new insights into how early treatment can change outcomes in JIA. She is a leader of SMART-JIA, a new international CARRA-PReS randomized controlled trial of treatments in polyarticular JIA patients who fail the first TNF inhibitor. She has also been on multiple guideline panels for the American College of Rheumatology. Lastly, she is the co PI of a newly NIH funded CARRA registry project that will prospectively assess the case definition, disease progression, biomarkers and patient reported outcomes in systemic JIA patients with a recently identified and potentially fatal complication of lung disease.

Share

Key dates

More speakers

Inoshi Atukorala - University Of Colombo

Inoshi Atukorala

University Of Colombo, South Asia
Tatsuya Atsumi - Hokkaido University

Tatsuya Atsumi

Hokkaido University, East Asia
Keishi Fujio - The University Of Tokyo

Keishi Fujio

The University Of Tokyo, East Asia
Yutaka Kawahito - Kyoto Prefectural University Of Medicine

Yutaka Kawahito

Kyoto Prefectural University Of Medicine, East Asia
Yoshiya Tanaka - University Of Occupational And Environmental Health

Yoshiya Tanaka

University Of Occupational And Environmental Health, Japan, East Asia
Gerd Burmester - Department of Rheumatology and Clinical Immunology

Gerd Burmester

Department of Rheumatology and Clinical Immunology, Charité, Europe